Edwards Lifesciences

Medical Devices

Edwards Lifesciences pioneered transcatheter heart valves that allow replacement of diseased valves without open-heart surgery. The company's TAVR technology transformed treatment for patients too frail for traditional surgery and has expanded to younger, lower-risk patients. Edwards leads the structural heart disease market and critical care monitoring.